Snakebite envenomation is a medical hazard that has a high public health impact, particularly in sub-Saharan Africa, Asia, and Latin America; other regions, such as Oceania and the Caribbean, are also affected by these envenomations [1]. Owing to its impact and to the fact that it predominantly affects impoverished rural populations, WHO adopted snakebite envenomation as a category A neglected tropical disease (NTD) in 2017, following a proposal presented by the government of Costa Rica and 17 additional countries [2]. WHO is currently working on a global plan to improve its control. Moreover, the WHO Executive Board has recently recommended a resolution on snakebite envenomation to the World Health Assembly [3]. These developments, together with additional efforts by diverse stakeholders, have prompted a growing interest on this public health problem in many regions. This viewpoint focuses on snakebites in the Caribbean, a region that includes a number of countries having venomous snakes, where this neglected disease has not received the attention it deserves.
